Drug therapy. Metoclopramide.
作者信息
Schulze-Delrieu K
出版信息
N Engl J Med. 1981 Jul 2;305(1):28-33. doi: 10.1056/NEJM198107023050106.
PMID:7015140
Abstract
摘要
相似文献
1
Drug therapy. Metoclopramide.药物治疗。甲氧氯普胺。
N Engl J Med. 1981 Jul 2;305(1):28-33. doi: 10.1056/NEJM198107023050106.
2
Metoclopramide.甲氧氯普胺
J Am Vet Med Assoc. 1983 Dec 1;183(11):1341-3.
3
Dopamine antagonists in the upper gastrointestinal tract.上消化道中的多巴胺拮抗剂。
Scand J Gastroenterol Suppl. 1984;96:127-36.
4
Review of the current status of prokinetic agents in gastroenterology.胃肠病学中促动力药物的现状综述
Am J Gastroenterol. 1985 Dec;80(12):1008-16.
5
Metoclopramide--a review.甲氧氯普胺——综述
Med J Aust. 1986 Mar 31;144(7):366-9. doi: 10.5694/j.1326-5377.1986.tb115923.x.
6
Metoclopramide: a dopamine receptor antagonist.甲氧氯普胺：一种多巴胺受体拮抗剂。
Am Fam Physician. 1990 Mar;41(3):919-24.
7
Prokinetic agents.促动力药
Gastroenterol Clin North Am. 1992 Sep;21(3):567-96.
8
Metoclopramide.甲氧氯普胺
Neonatal Netw. 1993 Jun;12(4):77-8.
9
Metoclopramide--a new pharmacological approach?胃复安——一种新的药理学方法？
Postgrad Med J. 1973 Jul;49 Suppl 4:suppl 4:9-13.
10
The anti-emetic effect of metoclopramide with an account of some experiments to assess the effect of the drug on gastric emptying in early labour.
Postgrad Med J. 1973 Jul;49 Suppl 4:suppl 4:51-2.
引用本文的文献
1
Case report: metoclopramide induced acute dystonic reaction in adolescent CYP2D6 poor metabolizers.病例报告：甲氧氯普胺在青少年CYP2D6慢代谢者中诱发急性肌张力障碍反应。
Front Pharmacol. 2023 Jul 11;14:1201566. doi: 10.3389/fphar.2023.1201566. eCollection 2023.
2
MSBIS: A Multi-Step Biomedical Informatics Screening Approach for Identifying Medications that Mitigate the Risks of Metoclopramide-Induced Tardive Dyskinesia.MSBIS：一种多步骤生物医学信息学筛选方法，用于识别减轻甲氧氯普胺引起的迟发性运动障碍风险的药物。
EBioMedicine. 2017 Dec;26:132-137. doi: 10.1016/j.ebiom.2017.11.015. Epub 2017 Nov 22.
3
Metoclopramide-induced cardiac arrest.甲氧氯普胺引起的心脏骤停。
Clin Pract. 2011 Nov 2;1(4):e83. doi: 10.4081/cp.2011.e83. eCollection 2011 Sep 28.
4
Risks and benefits of drugs used in the management of postoperative nausea and vomiting.用于术后恶心呕吐管理的药物的风险与益处。
Drug Saf. 1996 Mar;14(3):181-97. doi: 10.2165/00002018-199614030-00005.
5
Is the pharmacological treatment of cancer cachexia possible?癌症恶病质的药物治疗是否可行？
Support Care Cancer. 1993 Nov;1(6):298-304. doi: 10.1007/BF00364967.
6
Effects of cholinoceptor and 5-hydroxytryptamine3 receptor antagonism on erythromycin-induced canine intestinal motility disruption and emesis.胆碱受体和5-羟色胺3受体拮抗作用对红霉素诱导的犬肠道运动紊乱和呕吐的影响。
Br J Pharmacol. 1993 Jan;108(1):44-9. doi: 10.1111/j.1476-5381.1993.tb13437.x.
7
Palliative medicine.姑息医学
Postgrad Med J. 1993 Jun;69(812):429-49. doi: 10.1136/pgmj.69.812.429.
8
The effects of metoclopramide on acetylcholine release and on smooth muscle response in the isolated guinea-pig ileum.胃复安对豚鼠离体回肠乙酰胆碱释放及平滑肌反应的影响。
Naunyn Schmiedebergs Arch Pharmacol. 1982 Jun;319(3):231-8. doi: 10.1007/BF00495871.
9
Effect of metoclopramide on maternal and fetal hyperprolactinemia.甲氧氯普胺对母体及胎儿高催乳素血症的影响。
J Endocrinol Invest. 1983 Apr;6(2):107-11. doi: 10.1007/BF03350581.
10
The gastrointestinal tract in chemotherapy-induced emesis. A final common pathway.化疗所致呕吐中的胃肠道。一条最终共同通路。
Drugs. 1983 Feb;25 Suppl 1:18-34. doi: 10.2165/00003495-198300251-00004.
Zotero 插件